In today’s increasingly global, 24/7 workplace, the need for maintaining a work-life balance has never been more important. The Griffith...
Improving the delivery of acute wound care services in hospital is the focus of a new NHMRC Centre of Research Excellence.
The Federal Government’s $4 000 baby bonus is an expensive way to lift the birth-rate and is unneeded according to...
Last month the Griffith research team for the Australian Centre for International Agricultural Research (ACIAR) Indo-Pacific Initiative for Sustainable Animal...
Explore intelligent wealth-building insights: assess risk objectively, avoid herd mentality, and overcome overconfidence in navigating investments. Success lies not just in making money but in safeguarding it—creating a resilient financial foundation for the future says Dr John Fan.
Cyclones have significantly affected the Queensland tourism industry. One thing that has become abundantly clear: industry-wide preparation is the key to mitigating the devastating impact of natural disasters says Dr Yawei Jiang.
The first-ever adaptive clinical trial for Australians living with MS will seek to reverse neurological damage caused by progressive multiple sclerosis.
Griffith University’s Institute for Glycomics has received a $5 million philanthropic donation from the International Leducq Foundation to further the development of a Strep A vaccine.
Strep A (Streptococcus pyogenes) is a major cause of infection-related deaths, leading to over 500,000 fatalities annually. Developing countries, Indigenous populations, and vulnerable groups face the greatest risks. A potential vaccine, developed by Professor Michael Good's team at Griffith University, is undergoing human trials and shows promise in fighting multiple Strep A strains.
A collaboration between the Relational Insights Data Lab and Queensland Fire and Emergency Services aimed to better understand where, when, and how people move during a disaster in order to inform the states response strategy. Here is what they found.
